Source: BEFREE

Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1800629
rs1800629
TNF
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 GeneticVariation BEFREE The meta-analysis suggests that TNF-α rs1800629 polymorphism is associated with the increased risk of gastric cancer in Caucasians. 24142527

2014

dbSNP: rs1800629
rs1800629
TNF
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 GeneticVariation BEFREE A functional polymorphism, -308G>A (rs1800629), which is located in the promoter of TNFA gene, has been suggested to alter the production of TNF-α and influence cancer risk. 24072494

2014

dbSNP: rs1800629
rs1800629
TNF
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.040 GeneticVariation BEFREE The meta-analysis suggests that TNF-α rs1800629 polymorphism is associated with the increased risk of gastric cancer in Caucasians. 24142527

2014

dbSNP: rs1800629
rs1800629
TNF
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 GeneticVariation BEFREE A functional polymorphism, -308G>A (rs1800629), which is located in the promoter of TNFA gene, has been suggested to alter the production of TNF-α and influence cancer risk. 24072494

2014

dbSNP: rs1800629
rs1800629
TNF
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 GeneticVariation BEFREE A functional polymorphism, -308 G>A (rs1800629), which is located in the promoter of TNFA gene, has been suggested to alter the production of TNF-α and influence cancer risk. 23326309

2013

dbSNP: rs1800629
rs1800629
TNF
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 GeneticVariation BEFREE A functional polymorphism, -308 G>A (rs1800629), which is located in the promoter of TNFA gene, has been suggested to alter the production of TNF-α and influence cancer risk. 23326309

2013

dbSNP: rs1800629
rs1800629
TNF
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.040 GeneticVariation BEFREE Statistical analysis results showed significant association of SNPs rs9344, rs1799931, and rs1800629 with the risk of gastric cancer. 23072573

2013

dbSNP: rs1800629
rs1800629
TNF
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 GeneticVariation BEFREE Statistical analysis results showed significant association of SNPs rs9344, rs1799931, and rs1800629 with the risk of gastric cancer. 23072573

2013

dbSNP: rs1800629
rs1800629
TNF
CUI: C0243026
Disease: Sepsis
Sepsis
0.040 GeneticVariation BEFREE The minor allele frequency of rs1800629 was significantly higher in severe sepsis patients than that in both healthy controls (P(adj) = 0.00046, odds ratio (OR)(adj) = 1.92) and sepsis patients (P(adj) = 0.002, OR(adj) = 1.56). 23029405

2012

dbSNP: rs1800629
rs1800629
TNF
CUI: C0024117
Disease: Chronic Obstructive Airway Disease
Chronic Obstructive Airway Disease
0.040 GeneticVariation BEFREE Of these variants, four were significantly associated with COPD susceptibility in random effects meta-analysis, the GSTM1 null variant (OR 1.45, CI 1.09-1.92), rs1800470 in TGFB1 (0.73, CI 0.64-0.83), rs1800629 in TNF (OR 1.19, CI 1.01-1.40) and rs1799896 in SOD3 (OR 1.97, CI 1.24-3.13). 19933216

2010

dbSNP: rs1800629
rs1800629
TNF
Diabetes Mellitus, Insulin-Dependent
0.040 GeneticVariation BEFREE Initially, association with T1D was seen for LT-alpha A1069G (intron A, p=0.011, rs909253) and TNF G(-308)A (p<1x10(-5), rs1800629), but no association was observed for TNF G(-238)A (rs361525). 17174749

2006

dbSNP: rs1800629
rs1800629
TNF
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.030 GeneticVariation BEFREE Our analysis indicated no significant correlation between TNF-α-308G/A polymorphism (rs1800629) and CRC risk. 30610785

2019

dbSNP: rs1800629
rs1800629
TNF
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.030 GeneticVariation BEFREE The association of <i>TNF</i>-α <b>-</b>308 G>A (rs1800629) single-nucleotide polymorphism (SNP) with CRC risk has been investigated by many studies but the results are inconclusive. 30509964

2019

dbSNP: rs1800629
rs1800629
TNF
CUI: C0010068
Disease: Coronary heart disease
Coronary heart disease
0.030 GeneticVariation BEFREE These results indicate that higher level of serum TNF-α increases risk of CHD, while TNF-α rs1800629 A allele might contribute to higher risk for CHD due to the increase in TNF-α expression. 31324728

2019

dbSNP: rs1800629
rs1800629
TNF
CUI: C0024141
Disease: Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
0.030 GeneticVariation BEFREE Previous studies have investigated the association of TNF-α-238G/A (rs361525) and -308G/A (rs1800629) polymorphisms with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). 30916218

2019

dbSNP: rs1800629
rs1800629
TNF
CUI: C0038013
Disease: Ankylosing spondylitis
Ankylosing spondylitis
0.030 GeneticVariation BEFREE While <i>TNF</i>-308 (rs1800629) AA/GA, <i>IL17A</i> (rs2275913) AA/GA, and <i>IL17F</i> (rs763780) CC/TC genotype frequencies were associated, in the dominance inheritance model, with SpA and AS, regardless of gender, the presence of <i>HLA-B27</i>, <i>TNF</i>-238 (rs361525) GA/AA, <i>IL17A</i> (rs2275913) AA/GA, and <i>IL17F</i> (rs763780) genotypes was associated with PsA. 29849482

2018

dbSNP: rs1800629
rs1800629
TNF
CUI: C0038013
Disease: Ankylosing spondylitis
Ankylosing spondylitis
0.030 GeneticVariation BEFREE We replicated associations between AS and the polymorphisms in TNF (rs1800629), TNFRSF1A (rs4149570), and IL23R (rs11209026). 30208882

2018

dbSNP: rs1800629
rs1800629
TNF
CUI: C0010068
Disease: Coronary heart disease
Coronary heart disease
0.030 GeneticVariation BEFREE Promoter variants of TNF-α rs1800629 and IL-10 rs1800871 are independently associated with the susceptibility of coronary artery disease in north Indian. 29734056

2018

dbSNP: rs1800629
rs1800629
TNF
CUI: C0038013
Disease: Ankylosing spondylitis
Ankylosing spondylitis
0.030 GeneticVariation BEFREE For rs1800629, the A allele was also linked to reduced risk of AS (p < 0.0001, OR = 0.54, 95% CI = 0.39-0.74). 29230494

2018

dbSNP: rs1800629
rs1800629
TNF
CUI: C0024141
Disease: Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
0.030 GeneticVariation BEFREE An association between SLE and the rs1800629 polymorphism was established under the allelic model (allele A vs. allele G; odds ratios [OR] = 2.317), the dominant model (GA+AA vs. GG; OR = 3.214), and the overdominant model (GA vs. AA+GG; OR = 3.494). 29298134

2018

dbSNP: rs1800629
rs1800629
TNF
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.030 GeneticVariation BEFREE The influence of the <i>TNFα</i> rs1800629 polymorphism on some inflammatory biomarkers in 45-60-year-old women with metabolic syndrome. 30383538

2018

dbSNP: rs1800629
rs1800629
TNF
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.030 GeneticVariation BEFREE In conclusion, TNF-α rs1800629 polymorphism confers susceptibility to OA, especially among Asians. 29846433

2018

dbSNP: rs1800629
rs1800629
TNF
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.030 GeneticVariation BEFREE The purpose of the present case-control study was to investigate a possible association of four cytokine single nucleotide polymorphisms (SNPs), IL-4R -3223C>T (rs2057768), IL-8 -251T>A (rs4073), IL-10 -1082A>G (rs1800896) and TNF -A-308G>A (rs1800629) with OA susceptibility. 30186498

2018

dbSNP: rs1800629
rs1800629
TNF
CUI: C0024141
Disease: Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
0.030 GeneticVariation BEFREE The TNF -238G/A (rs361525) and -308G/A (rs1800629) polymorphisms have consistently been associated with systemic lupus erythematosus (SLE) in several populations; however, these findings have not been verified in all populations. 29611038

2018

dbSNP: rs1800629
rs1800629
TNF
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.030 GeneticVariation BEFREE The results also showed a significant association between rs1800629 and an IBD-associated CRC population (heterozygous model: OR 4.335, 95% CI 2.329-8.069, P < 0.001; homozygous model: OR 11.5, 95% CI 2.498-52.592, P = 0.002; dominant model: OR 4.986, 95% CI 2.754-9.026, P < 0.001; recessive model: OR 7.208, 95% CI 1.588-32.72, P = 0.01). 28243990

2017